Automated mobile technology for safe heart rhythm analysis at home
Official title: Novel, automated mobile heart rhythm analysis technology to start antiarrhythmic medications safely at home
Funded at Safebeat Rx INC. · NIH-11191222 · Data updated 2026-11-12
This study is testing a new mobile app that helps people with atrial fibrillation start their heart medication safely at home, using smart technology to check their heart rhythms and predict any side effects, so they can avoid hospital visits and get the care they need more easily.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Safebeat Rx INC. NIH-funded |
| Lab location | 1 site (Carson, UNITED STATES) |
| Project start | July 19, 2024 |
| Project end | June 30, 2026 |
| Funding year | 2025 |
| Award (this year) | $47,689 |
| NIH project number | 3R44HL167294-01A1S1 |
| Project ID | NIH-11191222 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients diagnosed with atrial fibrillation who are at low risk for heart rhythm complications.
✕Less likely to help
Patients with high-risk profiles for arrhythmias or those who require immediate medical supervision will not benefit from this research.
What this research studies
This research focuses on developing a novel mobile technology that allows patients with atrial fibrillation to safely start antiarrhythmic medications from home. By utilizing a machine learning algorithm, the technology analyzes heart rhythm data to predict potential side effects of these medications, which traditionally require hospitalization for monitoring. This approach aims to reduce the need for hospital stays, making treatment more accessible and convenient for patients. The technology provides accurate QTc interval measurements from electrocardiograms, enabling personalized medication dosing with high precision.
Why it matters
Potential benefit: If successful, this research could significantly improve the quality of life for atrial fibrillation patients by allowing them to initiate treatment safely at home without hospitalization.
How similar studies have gone: Other research has shown promise in using mobile technology and machine learning for heart rhythm monitoring, indicating a potential for success in this novel approach.
Where this research is happening
-
Safebeat Rx INC.
Carson, United States Active
Researchers
- Principal investigator: Navara, Rachita — Safebeat Rx INC.
- Study coordinator: Navara, Rachita
Related research
Other NIH-funded projects on the same topics.
-
Start antiarrhythmic medicine safely at home with an automated heart-monitoring kit
A home monitoring kit uses automated ECG and wearable defibrillator technology to help people with atrial fibrillation begin antiarrhythmic medicines without a three-day hospital stay.
-
A new technology to safely start heart rhythm medications at home using smartwatches
This study is testing a new smartwatch system that helps people with atrial fibrillation start their heart medication safely at home, so they can monitor their heart health and stay in touch with their doctors without needing to go to the hospital.
-
Automated technology for safe home management of heart rhythm medications
This study is testing a new mobile technology that helps people with atrial fibrillation start heart medications safely at home, making it easier for those who may not have easy access to doctors or hospitals.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.